BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szlasa W, Zendran I, Zalesińska A, Tarek M, Kulbacka J. Lipid composition of the cancer cell membrane. J Bioenerg Biomembr 2020;52:321-42. [PMID: 32715369 DOI: 10.1007/s10863-020-09846-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Pasello M, Giudice AM, Cristalli C, Manara MC, Mancarella C, Parra A, Serra M, Magagnoli G, Cidre-Aranaz F, Grünewald TGP, Bini C, Lollini PL, Longhi A, Donati DM, Scotlandi K. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. Cell Oncol (Dordr) 2022. [PMID: 36149602 DOI: 10.1007/s13402-022-00713-5] [Reference Citation Analysis]
2 Koo DJ, Sut TN, Tan SW, Yoon BK, Jackman JA. Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge. IJMS 2022;23:10558. [DOI: 10.3390/ijms231810558] [Reference Citation Analysis]
3 Haider T, Soni V. “Response surface methodology and artificial neural network-based modeling and optimization of phosphatidylserine targeted nanocarriers for effective treatment of cancer: In vitro and in silico studies”. Journal of Drug Delivery Science and Technology 2022;75:103663. [DOI: 10.1016/j.jddst.2022.103663] [Reference Citation Analysis]
4 Kordias D, Kostara CE, Papadaki S, Verigos J, Bairaktari E, Magklara A. Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities. Cells 2022;11:2719. [DOI: 10.3390/cells11172719] [Reference Citation Analysis]
5 Wu JLY, Stordy BP, Nguyen LNM, Deutschman CP, Chan WCW. A proposed mathematical description of in vivo nanoparticle delivery. Adv Drug Deliv Rev 2022;:114520. [PMID: 36041671 DOI: 10.1016/j.addr.2022.114520] [Reference Citation Analysis]
6 Xu Y, Jin Y, Gao S, Wang Y, Qu C, Wu Y, Ding N, Dai Y, Jiang L, Liu S, Pan J. Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/7204415] [Reference Citation Analysis]
7 Heravi G, Jang H, Wang X, Long Z, Peng Z, Kim S, Liu W. Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment. Front Oncol 2022;12:942798. [DOI: 10.3389/fonc.2022.942798] [Reference Citation Analysis]
8 Kwiecińska K, Stachowicz-kuśnierz A, Korchowiec B, Roman M, Kwiatek WM, Jagusiak A, Roterman I, Korchowiec J. Congo Red as a Supramolecular Carrier System for Doxorubicin: An Approach to Understanding the Mechanism of Action. IJMS 2022;23:8935. [DOI: 10.3390/ijms23168935] [Reference Citation Analysis]
9 Ramos-Martín F, D'Amelio N. Biomembrane lipids: When physics and chemistry join to shape biological activity. Biochimie 2022:S0300-9084(22)00187-0. [PMID: 35926681 DOI: 10.1016/j.biochi.2022.07.011] [Reference Citation Analysis]
10 Tobias F, Hummon AB. Lipidomic comparison of 2D and 3D colon cancer cell culture models. J Mass Spectrom 2022;57:e4880. [PMID: 36028991 DOI: 10.1002/jms.4880] [Reference Citation Analysis]
11 Zhong W, Lin W, Yang Y, Chen D, Cao X, Xu M, Pan G, Chen H, Zheng J, Feng X, Yang LH, Lai C, Olkkonen VM, Xu J, Cui S, Yan D. An acquired phosphatidylinositol 4-phosphate transport initiates T-cell deterioration and leukemogenesis. Nat Commun 2022;13:4390. [PMID: 35906240 DOI: 10.1038/s41467-022-32104-7] [Reference Citation Analysis]
12 Mercado V, Olmos J. Bacteriocin Production by Bacillus Species: Isolation, Characterization, and Application. Probiotics Antimicrob Proteins 2022. [PMID: 35881232 DOI: 10.1007/s12602-022-09966-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Deskeuvre M, Lan J, Dierge E, Messens J, Riant O, Corbet C, Feron O, Frédérick R. Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) Insertion Peptides. Int J Pharm 2022;:122041. [PMID: 35868479 DOI: 10.1016/j.ijpharm.2022.122041] [Reference Citation Analysis]
14 Vergani E, Beretta GL, Aloisi M, Costantino M, Corno C, Frigerio S, Tinelli S, Dugo M, Accattatis FM, Granata A, Arnaboldi L, Rodolfo M, Perego P, Gatti L. Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma. Front Cell Dev Biol 2022;10:927118. [DOI: 10.3389/fcell.2022.927118] [Reference Citation Analysis]
15 Maja M, Mohammed D, Dumitru AC, Verstraeten S, Lingurski M, Mingeot-Leclercq MP, Alsteens D, Tyteca D. Surface cholesterol-enriched domains specifically promote invasion of breast cancer cell lines by controlling invadopodia and extracellular matrix degradation. Cell Mol Life Sci 2022;79:417. [PMID: 35819726 DOI: 10.1007/s00018-022-04426-8] [Reference Citation Analysis]
16 Pandey J, Dubey R, Kate A, Prasad B, Sinha A, Mishra MS. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement. Drug Res (Stuttg). [DOI: 10.1055/a-1824-4619] [Reference Citation Analysis]
17 Ferreri C, Sansone A, Chatgilialoglu C, Ferreri R, Amézaga J, Burgos MC, Arranz S, Tueros I. Critical Review on Fatty Acid-Based Food and Nutraceuticals as Supporting Therapy in Cancer. Int J Mol Sci 2022;23:6030. [PMID: 35682708 DOI: 10.3390/ijms23116030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Blanco-gonzález A, Piñeiro Á, García-fandiño R. Unravelling hierarchical levels of structure in lipid membranes. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.05.042] [Reference Citation Analysis]
19 Sun M, Chen X, Yang Z. Single cell mass spectrometry studies reveal metabolomic features and potential mechanisms of drug-resistant cancer cell lines. Analytica Chimica Acta 2022;1206:339761. [DOI: 10.1016/j.aca.2022.339761] [Reference Citation Analysis]
20 Beckmann L, Tretbar US, Kitte R, Tretbar M. Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids. Molecules 2022;27:2501. [DOI: 10.3390/molecules27082501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Lima TRR, de Oliveira Lima E, Delafiori J, Ramos Catharino R, Viana de Camargo JL, Pereira LC. Molecular signatures associated with diuron exposure on rat urothelial mitochondria. Toxicol Mech Methods 2022;:1-21. [PMID: 35379061 DOI: 10.1080/15376516.2022.2062271] [Reference Citation Analysis]
22 de Oliveira ECL, da Costa KS, Taube PS, Lima AH, Junior CDSDS. Biological Membrane-Penetrating Peptides: Computational Prediction and Applications. Front Cell Infect Microbiol 2022;12:838259. [DOI: 10.3389/fcimb.2022.838259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bogusiewicz J, Kupcewicz B, Goryńska PZ, Jaroch K, Goryński K, Birski M, Furtak J, Paczkowski D, Harat M, Bojko B. Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes. Int J Mol Sci 2022;23:3518. [PMID: 35408879 DOI: 10.3390/ijms23073518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Li J, Kalyanram P, Rozati S, Monje-Galvan V, Gupta A. Interaction of Cyanine-D112 with Binary Lipid Mixtures: Molecular Dynamics Simulation and Differential Scanning Calorimetry Study. ACS Omega 2022;7:9765-74. [PMID: 35350357 DOI: 10.1021/acsomega.1c07378] [Reference Citation Analysis]
25 Delahunty I, Li J, Jiang W, Lee C, Yang X, Kumar A, Liu Z, Zhang W, Xie J. 7-Dehydrocholesterol Encapsulated Polymeric Nanoparticles As a Radiation-Responsive Sensitizer for Enhancing Radiation Therapy. Small 2022;:e2200710. [PMID: 35304816 DOI: 10.1002/smll.202200710] [Reference Citation Analysis]
26 Kovacs T, Zakany F, Nagy P. It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases. Cancers (Basel) 2022;14:944. [PMID: 35205690 DOI: 10.3390/cancers14040944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Bindra GK, Williams SA, Lay FT, Baxter AA, Poon IKH, Hulett MD, Phan TK. Human β-Defensin 2 (HBD-2) Displays Oncolytic Activity but Does Not Affect Tumour Cell Migration. Biomolecules 2022;12:264. [DOI: 10.3390/biom12020264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hein MJA, Kvansakul M, Lay FT, Phan TK, Hulett MD. Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics. Biochem Soc Trans 2022:BST20200884. [PMID: 35015081 DOI: 10.1042/BST20200884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lin T, Zhang E, Lin Z, Peng L. Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma. Int J Gen Med 2021;14:9117-30. [PMID: 34876845 DOI: 10.2147/IJGM.S344723] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Lobasso S, Tanzarella P, Mannavola F, Tucci M, Silvestris F, Felici C, Ingrosso C, Corcelli A, Lopalco P. A Lipidomic Approach to Identify Potential Biomarkers in Exosomes From Melanoma Cells With Different Metastatic Potential. Front Physiol 2021;12:748895. [PMID: 34867454 DOI: 10.3389/fphys.2021.748895] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Torres M, Parets S, Fernández-Díaz J, Beteta-Göbel R, Rodríguez-Lorca R, Román R, Lladó V, Rosselló CA, Fernández-García P, Escribá PV. Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids. Membranes (Basel) 2021;11:919. [PMID: 34940418 DOI: 10.3390/membranes11120919] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
32 Braný D, Dvorská D, Strnádel J, Matáková T, Halašová E, Škovierová H. Effect of Cold Atmospheric Plasma on Epigenetic Changes, DNA Damage, and Possibilities for Its Use in Synergistic Cancer Therapy. Int J Mol Sci 2021;22:12252. [PMID: 34830132 DOI: 10.3390/ijms222212252] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
33 Afify H, Ghoneum A, Almousa S, Abdulfattah AY, Warren B, Langsten K, Gonzalez D, Casals R, Bharadwaj M, Kridel S, Said N. Metabolomic credentialing of murine carcinogen-induced urothelial cancer. Sci Rep 2021;11:22085. [PMID: 34764423 DOI: 10.1038/s41598-021-99746-3] [Reference Citation Analysis]
34 Heymans V, Kunath S, Hajieva P, Moosmann B. Cell Culture Characterization of Prooxidative Chain-Transfer Agents as Novel Cytostatic Drugs. Molecules 2021;26:6743. [PMID: 34771157 DOI: 10.3390/molecules26216743] [Reference Citation Analysis]
35 Trofimenko E, Grasso G, Heulot M, Chevalier N, Deriu MA, Dubuis G, Arribat Y, Serulla M, Michel S, Vantomme G, Ory F, Dam LC, Puyal J, Amati F, Lüthi A, Danani A, Widmann C. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore. Elife 2021;10:e69832. [PMID: 34713805 DOI: 10.7554/eLife.69832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hilton KLF, Manwani C, Boles JE, White LJ, Ozturk S, Garrett MD, Hiscock JR. The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients. Chem Sci 2021;12:13273-82. [PMID: 34777745 DOI: 10.1039/d1sc03597e] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
37 Szlasa W, Kiełbik A, Szewczyk A, Novickij V, Tarek M, Łapińska Z, Saczko J, Kulbacka J, Rembiałkowska N. Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy. Int J Mol Sci 2021;22:11245. [PMID: 34681903 DOI: 10.3390/ijms222011245] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Víglaš J, Dobiasová S, Viktorová J, Ruml T, Repiská V, Olejníková P, Gbelcová H. Peptaibol-Containing Extracts of Trichoderma atroviride and the Fight against Resistant Microorganisms and Cancer Cells. Molecules 2021;26:6025. [PMID: 34641569 DOI: 10.3390/molecules26196025] [Reference Citation Analysis]
39 Mir SA, Wong SBJ, Narasimhan K, Esther CWL, Ji S, Burla B, Wenk MR, Tan DSP, Bendt AK. Lipidomic Analysis of Archival Pathology Specimens Identifies Altered Lipid Signatures in Ovarian Clear Cell Carcinoma. Metabolites 2021;11:597. [PMID: 34564414 DOI: 10.3390/metabo11090597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Paolino G, Huber V, Camerini S, Casella M, Macone A, Bertuccini L, Iosi F, Moliterni E, Cecchetti S, Ruspantini I, Chiarotti F, Vergani E, Lalli L, Raggi C, Di Biase A, Calvieri S, Mercuri SR, Lugini L, Federici C. The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients. Cancers (Basel) 2021;13:4157. [PMID: 34439311 DOI: 10.3390/cancers13164157] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Casagrande N, Borghese C, Gabbatore L, Morbiato L, De Zotti M, Aldinucci D. Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids. Int J Mol Sci 2021;22:8362. [PMID: 34445069 DOI: 10.3390/ijms22168362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Liu X, Zhong X, Li C. Challenges in cell membrane-camouflaged drug delivery systems: Development strategies and future prospects. Chinese Chemical Letters 2021;32:2347-58. [DOI: 10.1016/j.cclet.2021.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
43 Bakare OO, Gokul A, Wu R, Niekerk LA, Klein A, Keyster M. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer. Biomolecules 2021;11:1120. [PMID: 34439786 DOI: 10.3390/biom11081120] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
44 Tu A, Said N, Muddiman DC. Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging. Metabolomics 2021;17:70. [PMID: 34287708 DOI: 10.1007/s11306-021-01819-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
45 Alapati K, Handanahal SS. Cytotoxic activity of cholesterol oxidase produced by Streptomyces sp. AKHSS against cancerous cell lines: mechanism of action in HeLa cells. World J Microbiol Biotechnol 2021;37:141. [PMID: 34287712 DOI: 10.1007/s11274-021-03076-5] [Reference Citation Analysis]
46 Phyo P, Zhao X, Templeton AC, Xu W, Cheung JK, Su Y. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy. Adv Drug Deliv Rev 2021;174:1-29. [PMID: 33609600 DOI: 10.1016/j.addr.2021.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
47 Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, Frey B, Schlücker E, Gekle S, Gaipl US. In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy. Cells 2021;10:1436. [PMID: 34201238 DOI: 10.3390/cells10061436] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Ji W, Peng Z, Sun B, Chen L, Zhang Q, Guo M, Su C. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. Front Oncol 2021;11:678714. [PMID: 34178664 DOI: 10.3389/fonc.2021.678714] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Madan B, Virshup DM, Nes WD, Leaver DJ. Unearthing the Janus-face cholesterogenesis pathways in cancer. Biochem Pharmacol 2021;:114611. [PMID: 34010597 DOI: 10.1016/j.bcp.2021.114611] [Reference Citation Analysis]
50 da Silva RLCG, de Oliveira Gonçalves K, Courrol LC, Caseli L. Study of the interactions of gold nanoparticles functionalized with aminolevulinic acid in membrane models. Colloids Surf B Biointerfaces 2021;205:111849. [PMID: 34015730 DOI: 10.1016/j.colsurfb.2021.111849] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Lupo MG, Marchianò S, Adorni MP, Zimetti F, Ruscica M, Greco MF, Corsini A, Ferri N. PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin. Int J Mol Sci 2021;22:4114. [PMID: 33923431 DOI: 10.3390/ijms22084114] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Scipioni L, Rossetta A, Tedeschi G, Gratton E. Phasor S-FLIM: a new paradigm for fast and robust spectral fluorescence lifetime imaging. Nat Methods 2021;18:542-50. [PMID: 33859440 DOI: 10.1038/s41592-021-01108-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
53 Demir B, Moulahoum H, Ghorbanizamani F, Barlas FB, Yesiltepe O, Gumus ZP, Meral K, Odaci Demirkol D, Timur S. Carbon dots and curcumin-loaded CD44-Targeted liposomes for imaging and tracking cancer chemotherapy: A multi-purpose tool for theranostics. Journal of Drug Delivery Science and Technology 2021;62:102363. [DOI: 10.1016/j.jddst.2021.102363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Lin P, Dai L, Crooks DR, Neckers LM, Higashi RM, Fan TW, Lane AN. NMR Methods for Determining Lipid Turnover via Stable Isotope Resolved Metabolomics. Metabolites 2021;11:202. [PMID: 33805301 DOI: 10.3390/metabo11040202] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
55 Choromańska A, Chwiłkowska A, Kulbacka J, Baczyńska D, Rembiałkowska N, Szewczyk A, Michel O, Gajewska-Naryniecka A, Przystupski D, Saczko J. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy. Molecules 2021;26:1850. [PMID: 33806009 DOI: 10.3390/molecules26071850] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
56 Polit A, Mystek P, Błasiak E. Every Detail Matters. That Is, How the Interaction between Gα Proteins and Membrane Affects Their Function. Membranes (Basel) 2021;11:222. [PMID: 33804791 DOI: 10.3390/membranes11030222] [Reference Citation Analysis]
57 Ahmed B, Syed A, Ali K, Elgorban AM, Khan A, Lee J, Al-Shwaiman HA. Synthesis of gallotannin capped iron oxide nanoparticles and their broad spectrum biological applications. RSC Adv 2021;11:9880-93. [PMID: 35423492 DOI: 10.1039/d1ra00220a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
58 Sklias K, Santos Sousa J, Girard PM. Role of Short- and Long-Lived Reactive Species on the Selectivity and Anti-Cancer Action of Plasma Treatment In Vitro. Cancers (Basel) 2021;13:615. [PMID: 33557129 DOI: 10.3390/cancers13040615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
59 Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol 2020;10:615375. [PMID: 33604295 DOI: 10.3389/fonc.2020.615375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ramos-Martín F, D'Amelio N. Molecular Basis of the Anticancer and Antibacterial Properties of CecropinXJ Peptide: An In Silico Study. Int J Mol Sci 2021;22:E691. [PMID: 33445613 DOI: 10.3390/ijms22020691] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
61 Soteriou C, Kalli AC, Connell SD, Tyler AII, Thorne JL. Advances in understanding and in multi-disciplinary methodology used to assess lipid regulation of signalling cascades from the cancer cell plasma membrane. Prog Lipid Res 2021;81:101080. [PMID: 33359620 DOI: 10.1016/j.plipres.2020.101080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Puentes PR, Henao MC, Torres CE, Gómez SC, Gómez LA, Burgos JC, Arbeláez P, Osma JF, Muñoz-Camargo C, Reyes LH, Cruz JC. Design, Screening, and Testing of Non-Rational Peptide Libraries with Antimicrobial Activity: In Silico and Experimental Approaches. Antibiotics (Basel) 2020;9:E854. [PMID: 33265897 DOI: 10.3390/antibiotics9120854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
63 Mediratta K, El-Sahli S, D'Costa V, Wang L. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. Cancers (Basel) 2020;12:E3529. [PMID: 33256070 DOI: 10.3390/cancers12123529] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]